nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0599	0.126	CbGbCtD
Olopatadine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0564	0.119	CbGbCtD
Olopatadine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0564	0.119	CbGbCtD
Olopatadine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.051	0.107	CbGbCtD
Olopatadine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.051	0.107	CbGbCtD
Olopatadine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.044	0.0925	CbGbCtD
Olopatadine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0427	0.0898	CbGbCtD
Olopatadine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0386	0.0812	CbGbCtD
Olopatadine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0386	0.0812	CbGbCtD
Olopatadine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.037	0.0779	CbGbCtD
Olopatadine—S100B—nerve—acquired immunodeficiency syndrome	0.0158	0.0881	CbGeAlD
Olopatadine—S100A2—skin of body—acquired immunodeficiency syndrome	0.00724	0.0403	CbGeAlD
Olopatadine—S100A1—skin of body—acquired immunodeficiency syndrome	0.00667	0.0371	CbGeAlD
Olopatadine—S100B—retina—acquired immunodeficiency syndrome	0.00656	0.0365	CbGeAlD
Olopatadine—S100A13—skin of body—acquired immunodeficiency syndrome	0.00592	0.0329	CbGeAlD
Olopatadine—S100A2—lymphoid tissue—acquired immunodeficiency syndrome	0.00586	0.0326	CbGeAlD
Olopatadine—S100B—skin of body—acquired immunodeficiency syndrome	0.00576	0.032	CbGeAlD
Olopatadine—S100A1—digestive system—acquired immunodeficiency syndrome	0.00533	0.0297	CbGeAlD
Olopatadine—S100A2—vagina—acquired immunodeficiency syndrome	0.00512	0.0284	CbGeAlD
Olopatadine—S100A1—spinal cord—acquired immunodeficiency syndrome	0.0049	0.0272	CbGeAlD
Olopatadine—S100A2—lung—acquired immunodeficiency syndrome	0.00484	0.0269	CbGeAlD
Olopatadine—S100A13—digestive system—acquired immunodeficiency syndrome	0.00473	0.0263	CbGeAlD
Olopatadine—S100A12—lymphoid tissue—acquired immunodeficiency syndrome	0.00473	0.0263	CbGeAlD
Olopatadine—S100A12—digestive system—acquired immunodeficiency syndrome	0.00467	0.026	CbGeAlD
Olopatadine—S100B—lymphoid tissue—acquired immunodeficiency syndrome	0.00467	0.0259	CbGeAlD
Olopatadine—S100A12—blood—acquired immunodeficiency syndrome	0.00445	0.0247	CbGeAlD
Olopatadine—S100B—blood—acquired immunodeficiency syndrome	0.00439	0.0244	CbGeAlD
Olopatadine—S100A12—bone marrow—acquired immunodeficiency syndrome	0.0043	0.0239	CbGeAlD
Olopatadine—S100B—spinal cord—acquired immunodeficiency syndrome	0.00423	0.0235	CbGeAlD
Olopatadine—S100A1—nervous system—acquired immunodeficiency syndrome	0.00413	0.0229	CbGeAlD
Olopatadine—S100A12—vagina—acquired immunodeficiency syndrome	0.00412	0.0229	CbGeAlD
Olopatadine—S100A13—Indinavir—Nelfinavir—acquired immunodeficiency syndrome	0.00409	0.389	CbGdCrCtD
Olopatadine—S100A1—central nervous system—acquired immunodeficiency syndrome	0.00397	0.0221	CbGeAlD
Olopatadine—S100A13—lung—acquired immunodeficiency syndrome	0.00395	0.022	CbGeAlD
Olopatadine—S100A12—lung—acquired immunodeficiency syndrome	0.0039	0.0217	CbGeAlD
Olopatadine—S100A13—nervous system—acquired immunodeficiency syndrome	0.00366	0.0203	CbGeAlD
Olopatadine—S100B—nervous system—acquired immunodeficiency syndrome	0.00356	0.0198	CbGeAlD
Olopatadine—S100A13—central nervous system—acquired immunodeficiency syndrome	0.00352	0.0196	CbGeAlD
Olopatadine—S100B—central nervous system—acquired immunodeficiency syndrome	0.00343	0.0191	CbGeAlD
Olopatadine—S100A2—brain—acquired immunodeficiency syndrome	0.00342	0.019	CbGeAlD
Olopatadine—S100A13—Indinavir—Lopinavir—acquired immunodeficiency syndrome	0.00333	0.317	CbGdCrCtD
Olopatadine—S100A1—brain—acquired immunodeficiency syndrome	0.00315	0.0175	CbGeAlD
Olopatadine—S100A13—Indinavir—Saquinavir—acquired immunodeficiency syndrome	0.0031	0.295	CbGdCrCtD
Olopatadine—S100A1—lymph node—acquired immunodeficiency syndrome	0.00305	0.0169	CbGeAlD
Olopatadine—S100A13—brain—acquired immunodeficiency syndrome	0.0028	0.0156	CbGeAlD
Olopatadine—S100A12—brain—acquired immunodeficiency syndrome	0.00276	0.0153	CbGeAlD
Olopatadine—S100B—brain—acquired immunodeficiency syndrome	0.00272	0.0151	CbGeAlD
Olopatadine—S100A13—lymph node—acquired immunodeficiency syndrome	0.0027	0.015	CbGeAlD
Olopatadine—S100A12—lymph node—acquired immunodeficiency syndrome	0.00267	0.0148	CbGeAlD
Olopatadine—S100B—lymph node—acquired immunodeficiency syndrome	0.00263	0.0146	CbGeAlD
Olopatadine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.0019	0.0106	CbGeAlD
Olopatadine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000945	0.00525	CbGeAlD
Olopatadine—HRH1—vagina—acquired immunodeficiency syndrome	0.000835	0.00464	CbGeAlD
Olopatadine—HRH1—lung—acquired immunodeficiency syndrome	0.000789	0.00439	CbGeAlD
Olopatadine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000731	0.00406	CbGeAlD
Olopatadine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000731	0.00406	CbGeAlD
Olopatadine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000704	0.00391	CbGeAlD
Olopatadine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000696	0.00387	CbGeAlD
Olopatadine—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000585	0.00176	CcSEcCtD
Olopatadine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000584	0.00176	CcSEcCtD
Olopatadine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000581	0.00175	CcSEcCtD
Olopatadine—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000581	0.00175	CcSEcCtD
Olopatadine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000579	0.00174	CcSEcCtD
Olopatadine—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000578	0.00174	CcSEcCtD
Olopatadine—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000577	0.00174	CcSEcCtD
Olopatadine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000575	0.00173	CcSEcCtD
Olopatadine—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000574	0.00173	CcSEcCtD
Olopatadine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000571	0.00172	CcSEcCtD
Olopatadine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000571	0.00172	CcSEcCtD
Olopatadine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.00057	0.00172	CcSEcCtD
Olopatadine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00057	0.00172	CcSEcCtD
Olopatadine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000568	0.00171	CcSEcCtD
Olopatadine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000568	0.00171	CcSEcCtD
Olopatadine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000568	0.00171	CcSEcCtD
Olopatadine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000567	0.00171	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000567	0.00171	CcSEcCtD
Olopatadine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000566	0.0017	CcSEcCtD
Olopatadine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000566	0.0017	CcSEcCtD
Olopatadine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000565	0.00314	CbGeAlD
Olopatadine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000565	0.0017	CcSEcCtD
Olopatadine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000564	0.0017	CcSEcCtD
Olopatadine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000564	0.0017	CcSEcCtD
Olopatadine—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000564	0.0017	CcSEcCtD
Olopatadine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000562	0.00169	CcSEcCtD
Olopatadine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00056	0.00168	CcSEcCtD
Olopatadine—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000559	0.00168	CcSEcCtD
Olopatadine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000559	0.00168	CcSEcCtD
Olopatadine—HRH1—brain—acquired immunodeficiency syndrome	0.000559	0.00311	CbGeAlD
Olopatadine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000558	0.00168	CcSEcCtD
Olopatadine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000558	0.00168	CcSEcCtD
Olopatadine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000558	0.00168	CcSEcCtD
Olopatadine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000555	0.00167	CcSEcCtD
Olopatadine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000553	0.00167	CcSEcCtD
Olopatadine—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000552	0.00166	CcSEcCtD
Olopatadine—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00055	0.00166	CcSEcCtD
Olopatadine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000549	0.00165	CcSEcCtD
Olopatadine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000547	0.00164	CcSEcCtD
Olopatadine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000545	0.00164	CcSEcCtD
Olopatadine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000544	0.00302	CbGeAlD
Olopatadine—HRH1—lymph node—acquired immunodeficiency syndrome	0.00054	0.003	CbGeAlD
Olopatadine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000539	0.00162	CcSEcCtD
Olopatadine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000538	0.00162	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000537	0.00162	CcSEcCtD
Olopatadine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000537	0.00162	CcSEcCtD
Olopatadine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000536	0.00161	CcSEcCtD
Olopatadine—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000535	0.00161	CcSEcCtD
Olopatadine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000534	0.00161	CcSEcCtD
Olopatadine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000533	0.0016	CcSEcCtD
Olopatadine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000532	0.0016	CcSEcCtD
Olopatadine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000532	0.0016	CcSEcCtD
Olopatadine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000531	0.0016	CcSEcCtD
Olopatadine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00053	0.00159	CcSEcCtD
Olopatadine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000529	0.00159	CcSEcCtD
Olopatadine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000528	0.00159	CcSEcCtD
Olopatadine—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000527	0.00158	CcSEcCtD
Olopatadine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000525	0.00158	CcSEcCtD
Olopatadine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000525	0.00158	CcSEcCtD
Olopatadine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000524	0.00158	CcSEcCtD
Olopatadine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000523	0.00157	CcSEcCtD
Olopatadine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00052	0.00157	CcSEcCtD
Olopatadine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00052	0.00156	CcSEcCtD
Olopatadine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00052	0.00156	CcSEcCtD
Olopatadine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00052	0.00156	CcSEcCtD
Olopatadine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000517	0.00156	CcSEcCtD
Olopatadine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000517	0.00156	CcSEcCtD
Olopatadine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000516	0.00155	CcSEcCtD
Olopatadine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000515	0.00155	CcSEcCtD
Olopatadine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000515	0.00155	CcSEcCtD
Olopatadine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000515	0.00155	CcSEcCtD
Olopatadine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000514	0.00155	CcSEcCtD
Olopatadine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000513	0.00154	CcSEcCtD
Olopatadine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000509	0.00153	CcSEcCtD
Olopatadine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000508	0.00153	CcSEcCtD
Olopatadine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000508	0.00153	CcSEcCtD
Olopatadine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000508	0.00153	CcSEcCtD
Olopatadine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000507	0.00152	CcSEcCtD
Olopatadine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000506	0.00152	CcSEcCtD
Olopatadine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000505	0.00152	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000501	0.00151	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.0005	0.0015	CcSEcCtD
Olopatadine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000499	0.0015	CcSEcCtD
Olopatadine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000499	0.0015	CcSEcCtD
Olopatadine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000499	0.0015	CcSEcCtD
Olopatadine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000498	0.0015	CcSEcCtD
Olopatadine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000495	0.00149	CcSEcCtD
Olopatadine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000494	0.00149	CcSEcCtD
Olopatadine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000492	0.00148	CcSEcCtD
Olopatadine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000492	0.00148	CcSEcCtD
Olopatadine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000492	0.00148	CcSEcCtD
Olopatadine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000491	0.00148	CcSEcCtD
Olopatadine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00049	0.00147	CcSEcCtD
Olopatadine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00049	0.00147	CcSEcCtD
Olopatadine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000488	0.00147	CcSEcCtD
Olopatadine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000486	0.00146	CcSEcCtD
Olopatadine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000484	0.00146	CcSEcCtD
Olopatadine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000483	0.00145	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000483	0.00145	CcSEcCtD
Olopatadine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00048	0.00144	CcSEcCtD
Olopatadine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000477	0.00144	CcSEcCtD
Olopatadine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000475	0.00143	CcSEcCtD
Olopatadine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000475	0.00143	CcSEcCtD
Olopatadine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000475	0.00143	CcSEcCtD
Olopatadine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000475	0.00143	CcSEcCtD
Olopatadine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000474	0.00143	CcSEcCtD
Olopatadine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000473	0.00142	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000472	0.00142	CcSEcCtD
Olopatadine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000472	0.00142	CcSEcCtD
Olopatadine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000472	0.00142	CcSEcCtD
Olopatadine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00047	0.00141	CcSEcCtD
Olopatadine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000468	0.00141	CcSEcCtD
Olopatadine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000468	0.00141	CcSEcCtD
Olopatadine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000467	0.00141	CcSEcCtD
Olopatadine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000467	0.0014	CcSEcCtD
Olopatadine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000467	0.0014	CcSEcCtD
Olopatadine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000466	0.0014	CcSEcCtD
Olopatadine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000465	0.0014	CcSEcCtD
Olopatadine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000465	0.0014	CcSEcCtD
Olopatadine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000463	0.00139	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00046	0.00139	CcSEcCtD
Olopatadine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000458	0.00138	CcSEcCtD
Olopatadine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000458	0.00138	CcSEcCtD
Olopatadine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000458	0.00138	CcSEcCtD
Olopatadine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000457	0.00137	CcSEcCtD
Olopatadine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000457	0.00137	CcSEcCtD
Olopatadine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000455	0.00137	CcSEcCtD
Olopatadine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000453	0.00136	CcSEcCtD
Olopatadine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000453	0.00136	CcSEcCtD
Olopatadine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000453	0.00136	CcSEcCtD
Olopatadine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000452	0.00136	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000452	0.00136	CcSEcCtD
Olopatadine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000452	0.00136	CcSEcCtD
Olopatadine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000451	0.00136	CcSEcCtD
Olopatadine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000451	0.00136	CcSEcCtD
Olopatadine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000451	0.00136	CcSEcCtD
Olopatadine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00045	0.00135	CcSEcCtD
Olopatadine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000449	0.00135	CcSEcCtD
Olopatadine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000449	0.00135	CcSEcCtD
Olopatadine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000448	0.00135	CcSEcCtD
Olopatadine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000447	0.00135	CcSEcCtD
Olopatadine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000447	0.00134	CcSEcCtD
Olopatadine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000445	0.00134	CcSEcCtD
Olopatadine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000444	0.00134	CcSEcCtD
Olopatadine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000444	0.00134	CcSEcCtD
Olopatadine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000442	0.00133	CcSEcCtD
Olopatadine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000441	0.00133	CcSEcCtD
Olopatadine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000441	0.00133	CcSEcCtD
Olopatadine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00044	0.00133	CcSEcCtD
Olopatadine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000436	0.00131	CcSEcCtD
Olopatadine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000432	0.0013	CcSEcCtD
Olopatadine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000432	0.0013	CcSEcCtD
Olopatadine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000432	0.0013	CcSEcCtD
Olopatadine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.0013	CcSEcCtD
Olopatadine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000431	0.0013	CcSEcCtD
Olopatadine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00043	0.00129	CcSEcCtD
Olopatadine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000428	0.00129	CcSEcCtD
Olopatadine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000427	0.00128	CcSEcCtD
Olopatadine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000427	0.00128	CcSEcCtD
Olopatadine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000426	0.00128	CcSEcCtD
Olopatadine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000425	0.00128	CcSEcCtD
Olopatadine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000419	0.00126	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000418	0.00126	CcSEcCtD
Olopatadine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000417	0.00126	CcSEcCtD
Olopatadine—Acepromazine—ALB—acquired immunodeficiency syndrome	0.000416	0.251	CrCbGaD
Olopatadine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000415	0.00125	CcSEcCtD
Olopatadine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000415	0.00125	CcSEcCtD
Olopatadine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000414	0.00125	CcSEcCtD
Olopatadine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000414	0.00125	CcSEcCtD
Olopatadine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000414	0.00124	CcSEcCtD
Olopatadine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000414	0.00124	CcSEcCtD
Olopatadine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000412	0.00124	CcSEcCtD
Olopatadine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00041	0.00123	CcSEcCtD
Olopatadine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000403	0.00121	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000402	0.00121	CcSEcCtD
Olopatadine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000402	0.00121	CcSEcCtD
Olopatadine—Thiothixene—ALB—acquired immunodeficiency syndrome	0.0004	0.242	CrCbGaD
Olopatadine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000399	0.0012	CcSEcCtD
Olopatadine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000398	0.0012	CcSEcCtD
Olopatadine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000396	0.00119	CcSEcCtD
Olopatadine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000396	0.00119	CcSEcCtD
Olopatadine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000396	0.00119	CcSEcCtD
Olopatadine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000396	0.00119	CcSEcCtD
Olopatadine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000395	0.00119	CcSEcCtD
Olopatadine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000393	0.00118	CcSEcCtD
Olopatadine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000392	0.00118	CcSEcCtD
Olopatadine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000392	0.00118	CcSEcCtD
Olopatadine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00039	0.00117	CcSEcCtD
Olopatadine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000387	0.00116	CcSEcCtD
Olopatadine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000386	0.00116	CcSEcCtD
Olopatadine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000384	0.00116	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000384	0.00115	CcSEcCtD
Olopatadine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000383	0.00115	CcSEcCtD
Olopatadine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000383	0.00115	CcSEcCtD
Olopatadine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000383	0.00115	CcSEcCtD
Olopatadine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000383	0.00115	CcSEcCtD
Olopatadine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000381	0.00115	CcSEcCtD
Olopatadine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00038	0.00114	CcSEcCtD
Olopatadine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000376	0.00113	CcSEcCtD
Olopatadine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000374	0.00113	CcSEcCtD
Olopatadine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00037	0.00111	CcSEcCtD
Olopatadine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00037	0.00111	CcSEcCtD
Olopatadine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000368	0.00111	CcSEcCtD
Olopatadine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000368	0.00111	CcSEcCtD
Olopatadine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000368	0.00111	CcSEcCtD
Olopatadine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000366	0.0011	CcSEcCtD
Olopatadine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000365	0.0011	CcSEcCtD
Olopatadine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000365	0.0011	CcSEcCtD
Olopatadine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000363	0.00109	CcSEcCtD
Olopatadine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000363	0.00109	CcSEcCtD
Olopatadine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000362	0.00109	CcSEcCtD
Olopatadine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000358	0.00108	CcSEcCtD
Olopatadine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000357	0.00107	CcSEcCtD
Olopatadine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000351	0.00106	CcSEcCtD
Olopatadine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000351	0.00106	CcSEcCtD
Olopatadine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000348	0.00105	CcSEcCtD
Olopatadine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000347	0.00104	CcSEcCtD
Olopatadine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000346	0.00104	CcSEcCtD
Olopatadine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000345	0.00104	CcSEcCtD
Olopatadine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000345	0.00104	CcSEcCtD
Olopatadine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000344	0.00103	CcSEcCtD
Olopatadine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000343	0.00103	CcSEcCtD
Olopatadine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000343	0.00103	CcSEcCtD
Olopatadine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000342	0.00103	CcSEcCtD
Olopatadine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000334	0.00101	CcSEcCtD
Olopatadine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000333	0.001	CcSEcCtD
Olopatadine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000331	0.000996	CcSEcCtD
Olopatadine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00033	0.000993	CcSEcCtD
Olopatadine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00033	0.000992	CcSEcCtD
Olopatadine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00033	0.000992	CcSEcCtD
Olopatadine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000328	0.000987	CcSEcCtD
Olopatadine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000327	0.000985	CcSEcCtD
Olopatadine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000325	0.000978	CcSEcCtD
Olopatadine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.000963	CcSEcCtD
Olopatadine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000319	0.000959	CcSEcCtD
Olopatadine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000319	0.000959	CcSEcCtD
Olopatadine—Clomipramine—ALB—acquired immunodeficiency syndrome	0.000316	0.191	CrCbGaD
Olopatadine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000314	0.000946	CcSEcCtD
Olopatadine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000311	0.000935	CcSEcCtD
Olopatadine—Nortriptyline—ALB—acquired immunodeficiency syndrome	0.000309	0.187	CrCbGaD
Olopatadine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.000927	CcSEcCtD
Olopatadine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.000926	CcSEcCtD
Olopatadine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000305	0.000918	CcSEcCtD
Olopatadine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000305	0.000917	CcSEcCtD
Olopatadine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000304	0.000915	CcSEcCtD
Olopatadine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000303	0.000912	CcSEcCtD
Olopatadine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000296	0.000891	CcSEcCtD
Olopatadine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.000884	CcSEcCtD
Olopatadine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000294	0.000884	CcSEcCtD
Olopatadine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.000883	CcSEcCtD
Olopatadine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.000878	CcSEcCtD
Olopatadine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.000865	CcSEcCtD
Olopatadine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000283	0.00085	CcSEcCtD
Olopatadine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00028	0.000843	CcSEcCtD
Olopatadine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00028	0.000842	CcSEcCtD
Olopatadine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000278	0.000838	CcSEcCtD
Olopatadine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000277	0.000833	CcSEcCtD
Olopatadine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.000794	CcSEcCtD
Olopatadine—Amitriptyline—ALB—acquired immunodeficiency syndrome	0.000214	0.129	CrCbGaD
